Combination of EGFR-Directed Tyrosine Kinase Inhibitors (EGFR-TKI) with Radiotherapy in Brain Metastases from Non-Small Cell Lung Cancer: A 2010-2019 Retrospective Cohort Study

Shreya Saxena; Atulya Khosla; Ahmad Ozair; Rupesh Kotecha; Manmeet Ahluwalia

Combination of EGFR-Directed Tyrosine Kinase Inhibitors (EGFR-TKI) with Radiotherapy in Brain Metastases from Non-Small Cell Lung Cancer: A 2010-2019 Retrospective Cohort Study

Shreya Saxena
, Atulya Khosla
, Ahmad Ozair
, Rupesh Kotecha
, Manmeet Ahluwalia

Herbert Wertheim Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Cancers
Volume	15
State	Published - Jun 1 2023

Access to Document

Combination of EGFR-Directed Tyrosine Kinase Inhibitors (EGFR-TKIFinal published version, 460 KBLicense: Unspecified

Cite this

@article{1364624031de46e497e12ba7aa58d54d,

title = "Combination of EGFR-Directed Tyrosine Kinase Inhibitors (EGFR-TKI) with Radiotherapy in Brain Metastases from Non-Small Cell Lung Cancer: A 2010-2019 Retrospective Cohort Study",

author = "Shreya Saxena and Atulya Khosla and Ahmad Ozair and Rupesh Kotecha and Manmeet Ahluwalia",

note = "Tatineni, V., O'Shea, P. J., Saxena, S., Khosla, A. A., Ozair, A., Kotecha, R. R., Jia, X., Rauf, Y., Murphy, E. S., Chao, S. T., Suh, J. H., Peereboom, D. M., \& Ahluwalia, M. S. (2023). Combination of EGFR-Directed Tyrosine Kinase Inhibitors (EGFR-TKI) with Radiotherapy in Brain Metastases from Non-Small Cell Lung Cancer: A 2010-2019 Retrospective Cohort Study. Cancers, 15(11), 3015. https://doi.org/10.3390/cancers15113015",

year = "2023",

month = jun,

day = "1",

language = "American English",

volume = "15",

journal = "Cancers",

}

TY - JOUR

T1 - Combination of EGFR-Directed Tyrosine Kinase Inhibitors (EGFR-TKI) with Radiotherapy in Brain Metastases from Non-Small Cell Lung Cancer: A 2010-2019 Retrospective Cohort Study

AU - Saxena, Shreya

AU - Khosla, Atulya

AU - Ozair, Ahmad

AU - Kotecha, Rupesh

AU - Ahluwalia, Manmeet

N1 - Tatineni, V., O'Shea, P. J., Saxena, S., Khosla, A. A., Ozair, A., Kotecha, R. R., Jia, X., Rauf, Y., Murphy, E. S., Chao, S. T., Suh, J. H., Peereboom, D. M., & Ahluwalia, M. S. (2023). Combination of EGFR-Directed Tyrosine Kinase Inhibitors (EGFR-TKI) with Radiotherapy in Brain Metastases from Non-Small Cell Lung Cancer: A 2010-2019 Retrospective Cohort Study. Cancers, 15(11), 3015. https://doi.org/10.3390/cancers15113015

PY - 2023/6/1

Y1 - 2023/6/1

UR - https://scholarlycommons.baptisthealth.net/se-all-publications/5026

M3 - Article

VL - 15

JO - Cancers

JF - Cancers

ER -

Combination of EGFR-Directed Tyrosine Kinase Inhibitors (EGFR-TKI) with Radiotherapy in Brain Metastases from Non-Small Cell Lung Cancer: A 2010-2019 Retrospective Cohort Study

Access to Document

Other files and links

Cite this